Howard MaklerCo-founder and CEO, Innovation RefundsLatest in HomeSponsoredWhy Biocompatibility Plans Should Focus on Storytelling, Not Data DumpingApril 9, 2026Stryker Completes Acquisition of ZuriMEDOctober 26, 2026Neural Chip Decodes Interactions Between Brain RegionsOctober 23, 2026An mRNA Cancer Vaccine Helps Reduce Chances of Melanoma Patients' Tumors ReturningOctober 23, 2026Related StoriesHomeCybersecurity Through Data Storage StrategiesVideoSecurity Breach: Balancing the Light and Dark Forces of TechnologyHomeLighting the Path to Dark WarehousesSponsor ContentWhy Biocompatibility Plans Should Focus on Storytelling, Not Data Dumping